ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,663Medicare Part D Prescriptions Filled, Including Refills

Rank: 143 out of 890

$631K Total Retail Price of All Prescriptions

Rank: 180 out of 890

473 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 473 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 11,733 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
SIMVASTATIN 509 480 1 5
LEVOTHYROXINE SODIUM 455 400 2 2
AMLODIPINE BESYLATE 353 331 3 1
METFORMIN HCL 340 309 4 6
FUROSEMIDE 333 300 5 7
OMEPRAZOLE 296 267 6 8
LISINOPRIL 287 277 7 4
WARFARIN SODIUM 230 218 8 24
PRAVASTATIN SODIUM 228 225 9 10
SYNTHROID 203 199 10 53
CITALOPRAM HBR 193 164 11 20
HYDROCODONE-ACETAMINOPHEN 191 184 S3 12 3
AMLODIPINE BESYLATE-BENAZEPRIL 191 179 12 41
POTASSIUM CHLORIDE 188 177 14 11
GABAPENTIN 177 149 15 12
ZOLPIDEM TARTRATE 167 154 16 19
HYDROCHLOROTHIAZIDE 143 128 17 9
PANTOPRAZOLE SODIUM 130 130 18 34
MELOXICAM 126 91 19 18
FENOFIBRATE 122 121 20 74
NAMENDA 117 117 21 36
CLOPIDOGREL 112 106 22 28
ACTOS 111 108 23 88
KLOR-CON 10 108 99 24 189
NEXIUM 104 100 25 14
CARVEDILOL 97 97 26 22
METOPROLOL TARTRATE 97 84 26 15
TAMSULOSIN HCL 94 93 28 32
TRAMADOL HCL 93 88 29 16
JANUVIA 91 86 30 59
LORAZEPAM 90 89 31 195
AMITRIPTYLINE HCL 86 80 R 32 43
ATORVASTATIN CALCIUM 86 84 32 13
DIGOXIN 86 74 32 65
ATENOLOL 85 85 35 23
CYMBALTA 85 82 35 45
CLONIDINE HCL 83 72 37 35
BUMETANIDE 81 81 38 134
METOPROLOL SUCCINATE 80 79 39 17
ETODOLAC 78 62 40 197
CRESTOR 77 77 41 25
DIOVAN 76 76 42 33
QUETIAPINE FUMARATE 75 67 43 73
TRAZODONE HCL 74 63 44 40
PLAVIX 71 71 45 42
DONEPEZIL HCL 70 70 46 30
SERTRALINE HCL 68 67 47 26
ESCITALOPRAM OXALATE 66 66 48 51
NITROFURANTOIN 66 62 48 289
BENAZEPRIL HCL 64 63 50 44
BENICAR HCT 64 64 50 166
FLUTICASONE PROPIONATE 64 56 50 39
ALENDRONATE SODIUM 64 64 50 38
CIPROFLOXACIN HCL 62 61 54 58
PREDNISONE 60 60 55 47
GLIPIZIDE 59 59 56 62
ALPRAZOLAM 59 59 56 95
DOXAZOSIN MESYLATE 59 59 56 70
PROPRANOLOL HCL 58 58 59 141
GEMFIBROZIL 58 58 59 103
TRICOR 56 47 61 98
ALLOPURINOL 54 54 62 31
PIOGLITAZONE HCL 54 54 R 62 211
LACTULOSE 54 54 62 112
NIFEDIPINE ER 53 53 65 75
DILTIAZEM 24HR ER 53 30 65 149
TERAZOSIN HCL 52 52 67 142
VESICARE 52 52 67 188
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.